Journal article
In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy.
- Abstract:
-
BACKGROUND: Targeted splice modulation of pre-mRNA transcripts by antisense oligonucleotides (AOs) can correct the function of aberrant disease-related genes. Duchenne muscular dystrophy (DMD) arises as a result of mutations that interrupt the open-reading frame in the DMD gene encoding dystrophin such that dystrophin protein is absent, leading to fatal muscle degeneration. AOs have been shown to correct this dystrophin defect via exon skipping to yield functional dystrophin protein in animal...
Expand abstract
Actions
Authors
Bibliographic Details
- Journal:
- journal of gene medicine
- Volume:
- 12
- Issue:
- 4
- Pages:
- 354-364
- Publication date:
- 2010-04-01
- DOI:
- EISSN:
-
1521-2254
- ISSN:
-
1099-498X
- Source identifiers:
-
115563
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:115563
- UUID:
-
uuid:40628566-1f80-4a57-8fba-1d2ef6c43c76
- Local pid:
- pubs:115563
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2010
If you are the owner of this record, you can report an update to it here: Report update to this record